N-(1-naphthyl)-N-phenylformamide | 939358-36-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: N-(1-naphthyl)-N-phenylformamide
• 英文别名: N-naphthalen-1-yl-N-phenylformamide
• CAS: 939358-36-8
• 化学式: C₁₇H₁₃NO
• 分子量: 247.296
• InChiKey: KMWPUXLXGIIEES-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-(1-naphthyl)-N-phenylformamide 在 草酰氯 作用下， 以 二氯甲烷 为溶剂， 生成 N-dichloromethyl-N-(1-naphthyl)-N-phenylamine
  参考文献：
  名称：

  On the Formation and ¹H NMR-spectroscopic Characterization of N,N-Diaryl-substituted Formamide Chlorides

  摘要：

  N,N-二芳基取代甲酰胺与草酸氯酰发生反应，不会形成预期的盐类状甲酰胺氯化物，而是形成相应的非离子性N-二氯甲基取代的二芳胺。

  DOI：

  10.1515/znb-2012-0401
• 作为产物：
  描述：

  甲酸 、 N-苯基-1-萘胺 反应 6.0h， 生成 N-(1-naphthyl)-N-phenylformamide
  参考文献：
  名称：

  On the Formation and ¹H NMR-spectroscopic Characterization of N,N-Diaryl-substituted Formamide Chlorides

  摘要：

  N,N-二芳基取代甲酰胺与草酸氯酰发生反应，不会形成预期的盐类状甲酰胺氯化物，而是形成相应的非离子性N-二氯甲基取代的二芳胺。

  DOI：

  10.1515/znb-2012-0401

文献信息

• Fused pyramidine derivative and use thereof
  申请人：Hamamura Kazumasa

  公开号：US20070010537A1

  公开（公告）日：2007-01-11

  There are provided a fused pyrimidine compound having antagonistic activity against luteinizing hormone releasing hormone, and a medicine containing the compound. A luteinizing hormone releasing hormone antagonist containing a compound represented by the formula: wherein R 1a is a hydrocarbon group which may be substituted or a hydrogen atom, ring A a is a 6-membered aromatic ring which may be further substituted, ring B a is a homocyclic or heterocyclic ring which may be further substituted, W a is an oxygen atom or a sulfur atom, X a1 and X a2 , which may be identical or different, are each a hydrogen atom, a hydrocarbon group which may be substituted, or a heterocyclic group which may be substituted, or X a1 and X a2 together may form an oxygen atom, a sulfur atom or NR 3a (wherein R 3a is a hydrocarbon group which may be substituted or a hydrogen atom), and Y a is C 1-6 alkylene which may be substituted or a bond, or a salt or prodrug thereof.

  提供了一种融合嘧啶化合物，具有抗促黄体激素释放激素的拮抗活性，以及含有该化合物的药物。一种促黄体激素释放激素拮抗剂，包含以下式子所代表的化合物：其中，R1a是一个可以被取代的碳氢基团或氢原子，环A是一个可以进一步取代的6元芳香环，环B是一个可以进一步取代的同环或异环，Wa是一个氧原子或硫原子，Xa1和Xa2，可能相同或不同，是每个可以被取代的碳氢基团或杂环基团，或Xa1和Xa2在一起可以形成氧原子、硫原子或NR3a（其中R3a是一个可以被取代的碳氢基团或氢原子），而Y是C1-6烷基，可以被取代或成为键，或其盐或前药。
• FUSED PYRIMIDINE DERIVATIVE AND USE THEREOF
  申请人：Hamamura Kazumasa

  公开号：US20090062258A1

  公开（公告）日：2009-03-05

  The present invention provides a compound represented by the formula (I) and a salt thereof wherein: ring A is a 5-membered aromatic heterocycle optionally having substituent(s); R 1 is a hydrogen atom or a hydrocarbon group optionally having substituent(s); W is an oxygen atom or a sulfur atom; X 1 and X 2 may be the same or different and each is a hydrogen atom, a hydrocarbon group optionally having substituent(s) or a heterocyclic group, or, X 1 and X 2 in combination, optionally, form an oxygen atom, a sulfur atom or ═NR 2 ; ring B is an aromatic ring optionally further having substituent(s); Y is a bond, C 1-6 alkylene C 2-6 alkenylene or C 2-6 alkynylene, optionally having substituent(s); and Z is —SO n R 3 or —COR 4 , which are useful as a pharmaceutical agent having GnRH antagonistic action.

  本发明提供了一种由式(I)表示的化合物及其盐，其中：环A是一个可选具有取代基的5元芳香杂环；R1是氢原子或一个可选具有取代基的碳氢基；W是氧原子或硫原子；X1和X2可以相同或不同，每个都是氢原子、可选具有取代基的碳氢基或杂环基，或者X1和X2组合，可选地形成氧原子、硫原子或═NR2；环B是一个可选进一步具有取代基的芳香环；Y是键，C1-6烷基C2-6烯基或C2-6炔基，可选具有取代基；Z是—SOnR3或—COR4，其作为具有GnRH拮抗作用的药物剂使用。
• Hindered amine light stabilizers containing aromatic carboxy groups and derivatives
  申请人：ELF ATOCHEM NORTH AMERICA, INC.

  公开号：EP0294818A2

  公开（公告）日：1988-12-14

  There are provided hindered amine light stabilizers of the general formula wherein the hindered amine is attached to the nitrogen of an imide which also is attached to an aromatic group which contains a carboxy group and wherein R1 is, e.g., hydrogen or substituted or unsubstituted aliphatic of 1-20 carbons; Xis R2 is, e.g., oxyl, hydroxy or substituted or unsubstituted aliphatic acyl of 1-20 carbons; R3 is e.g., hydrogen or substituted or unsubstituted aliphatic of 1-20 carbons; A is, e.g., halogen or sulfate; and R4 is, e.g., hydroxy, halogen or a substituted or unsubstituted, mono or polyfunctional alcohol, amine, mercaptan or molecular mixture thereof, the carboxy group being a site for preparing unique derivatives, both polymeric and non-polymeric, useful as additives for preventing degradation of polymers and copolymers.

  提供了通式如下的受阻胺光稳定剂 其中受阻胺连接到亚胺的氮上，而亚胺也连接到含有羧基的芳香基团上，并且 R1 是氢或 1-20 个碳原子的取代或未取代的脂肪族； Xis R2 是，例如，氧、羟基或 1-20 个碳原子的取代或未取代的脂族酰基； R3 例如是氢或 1-20 个碳原子的取代或未取代的脂肪族； A 是卤素或硫酸盐；以及 R4 例如是羟基、卤素或取代或未取代的单官能或多官能醇、胺、硫醇或它们的分子混合物，羧基是制备独特衍生物的部位，包括聚合物和非聚合物，可用作防止聚合物和共聚物降解的添加剂。
• FUSED PYRIMIDINE DERIVATIVE AND USES THEREOF
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1847541A1

  公开（公告）日：2007-10-24

  A compound represented by the formula (I) wherein ring A is a 5-membered aromatic heterocycle optionally having substituent(s), R1 is a hydrogen atom or a hydrocarbon group optionally having substituent(s), W is an oxygen atom or a sulfur atom, X1 and X2 may be the same or different and each is a hydrogen atom, a hydrocarbon group optionally having substituent(s) or a heterocyclic group, or, X1 and X2 in combination optionally form an oxygen atom, a sulfur atom or =NR2, ring B is an aromatic ring optionally further having substituent(s), Y is a bond, C1-6 alkylene C2-6 alkenylene or C2-6 alkynylene, optionally having substituent(s), and Z is a group represented by formula: -SOnR3, or a group represented by formula: -COR4, or a salt thereof, is useful as a pharmaceutical agent having GnRH antagonistic action.

  由式 (I) 代表的化合物 其中环 A 是可选具有取代基的 5 元芳香杂环、 R1 是氢原子或可选具有取代基的烃基、 W 是氧原子或硫原子、 X1 和 X2 可以相同或不同，各自为氢原子、可选具有取代基的烃基或杂环基，或者，X1 和 X2 组合可选形成氧原子、硫原子或 =NR2、 环 B 是芳香环，可选择进一步具有取代基、 Y 是键、C1-6 亚烷基、C2-6 亚烯基或 C2-6 亚炔基，可选择具有取代基，以及 Z 是由式-SOnR3，或由式表示的基团：-COR4，或其盐，可用作具有 GnRH 拮抗作用的药剂。
• On the Formation and ¹H NMR-spectroscopic Characterization of N,N-Diaryl-substituted Formamide Chlorides
  作者：Jens Schönewerk、Horst Hartmann

  DOI：10.1515/znb-2012-0401

  日期：2012.4.1

  The reaction of N,N-diaryl-substituted formamides with oxalyl chloride gives rise, instead to the formation of the expected salt-like formamide chlorides, to the formation of corresponding non-ionic N-dichloromethyl-substituted diarylamines.

  N,N-二芳基取代甲酰胺与草酸氯酰发生反应，不会形成预期的盐类状甲酰胺氯化物，而是形成相应的非离子性N-二氯甲基取代的二芳胺。